Baker M E, Vaughn D A, Fanestil D D
J Supramol Struct. 1978;9(3):421-6. doi: 10.1002/jss.400090312.
Binding of steroid hormones is inhibited by protease inhibitors and substrates. The protease inhibitors phenylmethyl sulphonylfluoride, tosyl-lysine chloromethyl ketone, and tosylamide-phenylethyl-chloromethyl ketone and the protease substrates tosyl arginine methyl ester and tryptophan methyl ester eliminate specific binding of aldosterone, dexamethasone, dihydrotestosterone, estrogen, and progesterone to their respective receptors. These protease inhibitors and substrates also inhibit binding of progesterone to the 20,000 molecular weight mero-receptor formed from the progesterone receptor in chick oviduct. The binding of estradiol to rat alpha-fetoprotein is inhibited by the protease inhibitors and substrates but not by tryptophan or tryptophan amide, indicating the importance of an ester structure in the inhibition of steroid binding. Our results suggest that all steroid hormone receptors have a site with both common structural features and a role in the regulation of steroid hormone binding.
蛋白酶抑制剂和底物可抑制类固醇激素的结合。蛋白酶抑制剂苯甲基磺酰氟、甲苯磺酰赖氨酸氯甲基酮、甲苯磺酰胺-苯乙基-氯甲基酮以及蛋白酶底物甲苯磺酰精氨酸甲酯和色氨酸甲酯可消除醛固酮、地塞米松、二氢睾酮、雌激素和孕酮与其各自受体的特异性结合。这些蛋白酶抑制剂和底物还可抑制孕酮与由鸡输卵管中的孕酮受体形成的20,000分子量的亚受体的结合。蛋白酶抑制剂和底物可抑制雌二醇与大鼠甲胎蛋白的结合,但色氨酸或色氨酸酰胺则无此作用,这表明酯结构在抑制类固醇结合中具有重要作用。我们的结果表明,所有类固醇激素受体都有一个具有共同结构特征且在类固醇激素结合调节中起作用的位点。